Thomas J Schnitzer – Grants — Northwestern Scholars

View Scopus Profile

Phone+1 312 503 2315
Emailtjsnorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

17 Active
85 Finished

75 - 85 out of 85 results

Filter

Finished

Prot# C02-009: A Phase III, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects with Gout
Schnitzer, T. J.
TAP Pharmaceutical Products Inc.
4/5/04 → 3/1/05
Project: Research project
Prot# WL-1001-05-04: An Open Label Multicenter Study Evaluating the Safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis of the Knee(s)
Schnitzer, T. J.
Winston Laboratories, Inc.
3/23/04 → 12/31/06
Project: Research project
Prot# 211-10/FOS530: 12-Month Extension to: Rndmzd, Dbl-Blnd, Dbl-Dmmy, Prll-Grp, Mltcntr Study to Evaluate & Compare Effects of 1x Wkly Alendronate & Risedronate on Bone Mineral Density in Postmenopausal Women w/Osteoporosis (FACT - OSAMAX® ACTONAL® Comp
Schnitzer, T. J.
Merck & Co., Inc.
2/20/04 → 12/11/06
Project: Research project
Prot# CCOX189A2360E1: 39-Wk, Opn-Lbl, Ext'n to CCOX189A2360, a 13-Wk, Mlticntr, Rndmzd, Dbl-Bld, Dbl-Dummy, Plcbo-Cntrld, Prl'l-Trial of 2 Different Dose Regimens of Lumiracoxib(100mg od & 200mg od Initial Dose for 2 wks Flw'd by 100mg od) in Pt's w/ Prim
Schnitzer, T. J.
Novartis Pharmaceuticals Corporation
1/1/04 → 11/27/06
Project: Research project
Prot# 227-00: 15-Wk, Dbl-Blnd, Rndmzd, Active-Cntrlld, Mltcntr Study w/ 24-Wk Extension to Evaluate the Safety, Tolerability, & Efficacy of Alendronate 70-mg Plus Vitamin D3 2800 IU Combination Tablet in Men & Postmenopausal Women w/ Osteoporosis
Schnitzer, T. J.
Merck & Co., Inc.
11/12/03 → 2/2/07
Project: Research project
Prot# WL-1001-05-01: A Double-Blind, Randomized, Controlled, Parallel-Group, Multicenter Study Evaluating the Safety and Efficacy of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis of the Knee
Schnitzer, T. J.
Winston Laboratories, Inc.
9/8/03 → 12/31/06
Project: Research project
Prot# 219-00/COX540: A Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Study to Evaluate the Safety and Efficacy of Rofecoxib 12.5 mg and Celecoxib 200 mg in Patients with Osteoarthritis of the Knee
Schnitzer, T. J.
Merck & Co., Inc.
9/2/03 → 1/31/05
Project: Research project
Prot# 066-00: A Randomized, Double-Blind, Active-Comparator-Controlled, Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients with Osteoarthritis or Rheumatoid Arthritis
Schnitzer, T. J.
Merck & Co., Inc.
10/11/02 → 10/11/05
Project: Research project
Prot# SP-NON-0010: Phase II Study on Analgesic Efficacy, Safety & Tolerability of AR-P900758XX: A 6 Week, Rndmzd, Dbl-Bld, Placebo-Controlled, Dose-Finding, Mltctr Study Comparing AR-P900758XX w/ Vioxx® & w/ Naproxen in Subjects w/ Osteoarthritis of Knee
Schnitzer, T. J.
Rheumatology Research International (RRI), AstraZeneca Pharmaceuticals LP
3/11/02 → 5/16/07
Project: Research project
Prot# CZOL446H2301: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
Schnitzer, T. J.
PPD Development, Novartis Pharmaceuticals Corporation
1/11/02 → 8/1/06
Project: Research project